Bruno
Paiva
Profesional Investigador
Policlinico S.Orsola-Malpighi
Bolonia, ItaliaPublicaciones en colaboración con investigadores/as de Policlinico S.Orsola-Malpighi (4)
2023
-
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)
Leukemia
-
MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials
Blood, Vol. 141, Núm. 6, pp. 579-591
2022
-
Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, and MAIA
Blood, Vol. 139, Núm. 6, pp. 835-844
2021
-
Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multiple myeloma
Blood, Vol. 137, Núm. 9, pp. 1154-1165